Evaluation of metastatic potential of prostate cancer
We aimed to establish a method for evaluating malignant potential of prostate cancer using prostatic core needle biopsy (PCNB) before prostatectomy. If we can know the final pathological stage before treatment, we can select the most suitable therapeutic tactics. We then examined the expression of E...
Saved in:
Main Authors: | Yoshitomo Chihara (Author), Hiroki Kuniyasu (Author), Kiyohide Fujimoto (Author), Yoshihiko Hirao (Author) |
---|---|
Format: | Book |
Published: |
Frontiers Media S.A.,
2011-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
The roles of HMGB1 related angiogenesis and lymphangiogenesis in oral cancer
by: Hiroki Kuniyasu, et al.
Published: (2011) -
Metastatic prostate cancer masquerading as lymphangioma circumscriptum
by: Caroline A. Gerhardt, BS, et al.
Published: (2022) -
The Current Therapeutic Landscape for Metastatic Prostate Cancer
by: Anastasia Bernal, et al.
Published: (2024) -
HTA and innovative treatments evaluation: the case of metastatic castration-resistant prostate cancer
by: Bretoni A, et al.
Published: (2019) -
Enzalutamide for the treatment of metastatic castration-resistant prostate cancer
by: Rodriguez-Vida A, et al.
Published: (2015)